In December, the board had approved repurchasing $217 million of the company’s stock, or about 1.2 percent of the company’s outstanding shares.
In a news release, CEO Neal Patterson reiterated the repurchasing would be a good use of company funds, indicating he expects Cerner to continue the strong growth that characterized the company’s past two quarters.
“This program reflects our commitment to enhancing long-term shareholder value and our confidence in Cerner’s prospects as a leader in the growing healthcare industry,” said Mr. Patterson in the release.
More Articles on Cerner:
5 Takeaways From Cerner’s Annual Shareholders’ Meeting
7 Executives on Why They Selected Their Current EHR Vendor
4 Health IT Companies That Posted Increased Revenues in Q1
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
